Medical technology company Pexa has received an order from a US government customer that is one of the world's largest public funders of medical research. The reported assignment concerns an upgrade of an existing PExA 2.1 system to streamline sample collection and sample handling.The order value amounts to approximately SEK 250,000. The customer has previously used the company's technology for non-invasive sampling from the small airways and plans to continue patient sampling with proteomics as the prioritized area of analysis.